Belgian pharmaceutical company UCB announced Tuesday that it would invest $2 billion to build a drug-making plant in suburban Atlanta.
The rapidly growing drugmaker said the plant, which would employ about 330 people upon completion, would anchor its effort to sell more drugs in the United States.
